Autoimmune hepatitis (AIH) is a chronic portal inflammation of unknown etiology that can lead to cirrhosis and liver failure if not properly controlled. Current treatment of AIH relies on long-term systemic immune suppression. However, such therapy places patients at risk of severe side effects;moreover, a significant minority does not respond. The lack of a robust animal model for the disease has hampered progress in understanding the pathogenesis of this disease and improving diagnosis and treatment. Diacylglycerol kinases (DGKs) catalyze the conversion of diacylglycerol to phosphatidic acid through phosphorylation. We and others have recently demonstrated that DGK? and ?, isoforms expressed in T cells, negatively control T cell activation by inhibiting T cell receptor (TCR)-induced Ras and Erk1/2 activation. Deficiency of either DGK? or ? causes T cells to be hyperresponsive to TCR stimulation and resistant to anergy induction. Our central hypotheses for this application are that DGK? and ? synergistically contribute to self-tolerance to the liver and that loss of T cell-tolerance and dysfunction of regulatory T cells (Tregs) contribute to the pathogenesis of AIH. With strong preliminary data, we plan to use DGK? and ? doubly deficient (DGK?? DKO) mice to test our central hypotheses by pursuing three specific aims.
In aim 1, we will define DGK?? DKO mice as a relevant model for chronic AIH and liver fibrosis.
In aim 2, we will determine the role of T cell subsets in the pathogenesis of hepatitis in DGK?? DKO mice.
In aim 3, we will determine the signaling mechanisms that participate in the pathogenesis of AIH. The proposed studies should establish DGK?? DKO mice as a proper model for chronic AIH and liver fibrosis, improve understanding of the mechanisms involved in the pathogenesis of AIH, and provide new therapeutic strategies for the disease. PROJECT NARRATIVE This grant application aims to establish a long-awaited murine model of chronic autoimmune hepatitis and liver fibrosis and is directly relevant to FOA PA-07-012 entitled `Animal Models of NIDDK Relevant Diseases'and to the NIDDK Liver Diseases Research Action Plan. The proposed studies are expected to improve understanding of the pathogenesis of autoimmune hepatitis and provide therapeutic strategies for AIH and other autoimmune diseases.
|Shin, Jinwook; Wang, Shang; Deng, Wenhai et al. (2014) Mechanistic target of rapamycin complex 1 is critical for invariant natural killer T-cell development and effector function. Proc Natl Acad Sci U S A 111:E776-83|
|Krishna, Sruti; Yang, Jialong; Wang, Hongxia et al. (2014) Role of tumor suppressor TSC1 in regulating antigen-specific primary and memory CD8 T cell responses to bacterial infection. Infect Immun 82:3045-57|
|Wu, Jinhong; Yang, Jialong; Yang, Kai et al. (2014) iNKT cells require TSC1 for terminal maturation and effector lineage fate decisions. J Clin Invest 124:1685-98|
|Mousallem, Talal; Yang, Jialong; Urban, Thomas J et al. (2014) A nonsense mutation in IKBKB causes combined immunodeficiency. Blood 124:2046-50|
|Wu, Jinhong; Shin, Jinwook; Xie, Danli et al. (2014) Tuberous sclerosis 1 promotes invariant NKT cell anergy and inhibits invariant NKT cell-mediated antitumor immunity. J Immunol 192:2643-50|
|Shin, Jinwook; Zhang, Ping; Wang, Shang et al. (2013) Negative control of mast cell degranulation and the anaphylactic response by the phosphatase lipin1. Eur J Immunol 43:240-8|
|Shin, Jinwook; Xie, Danli; Zhong, Xiao-Ping (2013) MicroRNA-34a enhances T cell activation by targeting diacylglycerol kinase ýý. PLoS One 8:e77983|
|Gorentla, Balachandra K; Krishna, Sruti; Shin, Jinwook et al. (2013) Mnk1 and 2 are dispensable for T cell development and activation but important for the pathogenesis of experimental autoimmune encephalomyelitis. J Immunol 190:1026-37|
|Pan, Hongjie; O'Brien, Thomas F; Wright, Gabriela et al. (2013) Critical role of the tumor suppressor tuberous sclerosis complex 1 in dendritic cell activation of CD4 T cells by promoting MHC class II expression via IRF4 and CIITA. J Immunol 191:699-707|
|Kulis, Mike; Gorentla, Balachandra; Burks, A Wesley et al. (2013) Type B CpG oligodeoxynucleotides induce Th1 responses to peanut antigens: modulation of sensitization and utility in a truncated immunotherapy regimen in mice. Mol Nutr Food Res 57:906-15|
Showing the most recent 10 out of 24 publications